FDA shuffles top drug, biologics leaders in latest shakeup

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, April 22, 2025. Nathan Posner | Anadolu | Getty Images The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, according to a memo seen by CNBC, days after the departure of former commissioner Marty Makary. …